489427-21-6

Basic information

• Product Name: 4-{5-(2-hydroxyimino-1,1-dimethyl-propylamino)-3-[2-(2-hydroxyimino-1,1-dimethyl-propylamino)-ethyl]-pentylcarbamoyl}-thiobutyric acid 2,3,5,6-tetrafluoro-phenyl ester
• Synonyms: 4-{5-(2-hydroxyimino-1,1-dimethyl-propylamino)-3-[2-(2-hydroxyimino-1,1-dimethyl-propylamino)-ethyl]-pentylcarbamoyl}-thiobutyric acid 2,3,5,6-tetrafluoro-phenyl ester
• CAS NO: 489427-21-6
• Molecular Weight: 621.74
• Mol File: 489427-21-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-{5-(2-hydroxyimino-1,1-dimethyl-propylamino)-3-[2-(2-hydroxyimino-1,1-dimethyl-propylamino)-ethyl]-pentylcarbamoyl}-thiobutyric acid 2,3,5,6-tetrafluoro-phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{5-(2-hydroxyimino-1,1-dimethyl-propylamino)-3-[2-(2-hydroxyimino-1,1-dimethyl-propylamino)-ethyl]-pentylcarbamoyl}-thiobutyric acid 2,3,5,6-tetrafluoro-phenyl ester(489427-21-6)
• EPA Substance Registry System: 4-{5-(2-hydroxyimino-1,1-dimethyl-propylamino)-3-[2-(2-hydroxyimino-1,1-dimethyl-propylamino)-ethyl]-pentylcarbamoyl}-thiobutyric acid 2,3,5,6-tetrafluoro-phenyl ester(489427-21-6)

Safety Data

• Hazardous Substances Data: 489427-21-6(Hazardous Substances Data)

Upstream product

• 1830-54-2 3-oxopentanedioic acid dimethyl ester 
• 57056-37-8 3-(methoxycarbonyl)-methylpent-2-ene-1,5-dicarboxylic acid dimethylester 
• 57056-38-9 tris(methyloxycarbonylmethyl)methane 
• 110-46-3 isopentyl nitrite 
• 3467-86-5 2,3,4,5-Tetrafluorobenzenethiol 
• 488706-26-9 C₂₂H₄₃N₅O₅ 
• 37557-67-8 2-chloro-2-methyl-3-nitrosobutane 
• 513-35-9 2-methyl-but-2-ene 
• 460078-00-6 3-(2-aminoethyl)pentane-1,5-diamine 
• 488706-14-5 tris[2-(methylsulfonyloxy)ethyl]methane 
• 488706-16-7 1,1,1-tris(2-azidoethyl)methane 
• 53378-75-9 3-(2-hydroxyethyl)pentane-1,5-diol 
• 87986-82-1 tris(2-acetoxyethyl)methane 
• 488706-22-5 bis[N-(1,1-dimethyl-2-N-hydroxyiminepropyl)-2-aminoethyl]-(2-aminoethyl)methane 

Relevant articles and documents

Technetium labelled peptides

The present invention relates to technetium imaging agents comprising radiolabeled c-Met binding peptides suitable for SPECT or PET imaging in vivo. The c-Met binding peptides are labelled via chelator conjugates. Also disclosed are pharmaceutical compositions, methods of preparation of the agents and compositions, plus methods of in vivo imaging using the compositions, especially for use in the diagnosis of cancer.